The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol. 2000 Jan; 129(2):227-30.

View in: PubMed

subject areas

Amides
Arachidonic Acids
Binding, Competitive
Calcium
Calcium Channels
Cannabinoids
Capsaicin
Cell Line
Cloning, Molecular
Electrophysiology
Endocannabinoids
Ethanolamines
Humans
Hydrogen-Ion Concentration
Palmitic Acids
Patch-Clamp Techniques
Polyunsaturated Alkamides
Receptors, Drug
Recombinant Proteins
TRPV Cation Channels

authors with profiles

James Chambers

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support